期刊文献+

4-N-苯胺基喹啉衍生物的合成及胆碱酯酶抑制活性 被引量:1

Syntheses and Anti-cholinesterase Activity of 4-N-Phenylaminoquinoline Derivatives
下载PDF
导出
摘要 设计合成了一系列4-N-苯胺基喹啉类衍生物,采用Ellman法测定了目标化合物对乙酰胆碱酯酶(AChE)和丁酰胆碱酯酶(BChE)的抑制活性.结果表明,当喹啉环上连有伸长的吡啶季铵盐片段时,可显著提高目标化合物的胆碱酯酶抑制作用.化合物16对AChE和BChE具有明显的双重抑制作用,其IC_(50)值分别为0.92和14.20μmol/L,抑制效果强于阳性对照药加兰他敏. A series of 4-N-Phenylaminoquinoline derivatives was designed and synthesized, and their anti-cholinesterase activities were evaluated using Ellman assay. The results demonstrated that the stretched-out quaternary pyridine in quinoline ring greatly improved the cholinesterase inhibition of target compounds. Compound 16 exhibited the most potent inhibitory activities against both acetylcholinesterase(AChE) and bu- tyrylcholinesterase(BChE) from the prepared series, with IC50 values of 0. 92 and 14. 20 μmol/L, respective- ly, which showed superior activitities compared with the reference drug galanthamine. These results suggest that compound 16 may be valuable as a new parent compound for further structural modifications.
出处 《高等学校化学学报》 SCIE EI CAS CSCD 北大核心 2017年第3期392-397,共6页 Chemical Journal of Chinese Universities
基金 国家自然科学基金(批准号:81073153)资助~~
关键词 4-N-苯胺基喹啉类衍生物 胆碱酯酶抑制活性 构效关系 4-N-Phenylaminoquinoline derivatives Anti-cholinesterase activity Structure-activity relation-ship
  • 相关文献

参考文献5

二级参考文献35

  • 1李志良.定量构效关系研究进展[J].化学通报,1995(9):5-10. 被引量:37
  • 2Tiwari R. K. , Singh D. , Singh J. , Chhillar A. K. , Chandra R. , Verma A. K.. Eur. J. Med. Chem. [J]. 2006, 41:40-49.
  • 3CHEN Kai-Xian(陈凯先),JIANG Hua-Hang(蒋华良),JI Ru-Yun(嵇汝运) .Computer-assisted Drug Design Principle, Method and Application(计算机辅助药物设计:方法、原理及应用)[M],Shanghai: Shanghai Scientific and Technical Publishers, 2004:4.
  • 4Miyashita Y., Li Z., Sasaki S.. Trend Anal. Chem. [J], 1993, 12(2) : 50-60.
  • 5ParrR. G., Pearson R. G.. J. Am. Chem. Soc.[J], 1983, 105:7512-7516.
  • 6Singh P. P. , Srivastava H. K. , Pasha F. A.. Bio. Med. Chem. [J], 2004, 12:171-177.
  • 7Zhang L. , Wan J. , Yang G. F.. Bio. Med. Chem. [J] , 2004, 12:6183-6191.
  • 8Karelson M. , Lobanov V. S.. Chem. Rev. [J], 1996, 96:1027-1044.
  • 9Dragon 5.4, Evaluation Verion[CP] , Milano, TALETE S. r. 1. , 2006.
  • 10Narender P. , Srinivas U. , Ravinder M. , Ananda R. B. , Ramesh Ch. , Harakishore K. , Gangadasu B. , Murthy U. S. N. , Jayathirtha R. V.. Bioorganic & Medicinal Chemistry[ J], 2006, 14:4600-4609.

共引文献39

同被引文献19

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部